Colorado startup MBio Diagnostics raises a $6.3M Series B
The company doesn't say much about its platform, but that it uses multiplexing technology to seek out specific proteins, nucleic acids and small molecules.
The company doesn't say much about its platform, but that it uses multiplexing technology to seek out specific proteins, nucleic acids and small molecules.